drugset / Trial / NCT03851562

Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy

NCT03851562

RandomizedParallel-groupDouble-blindTreatment

Summary

Correction of the deficit in the perfusion pressure of the microcirculation that supplies the nerve by intravenous infusion of Prostaglandin E1 (PGE1) (Alprostadil), expected to improve visual function in patients with ischemic optic neuropathy previous non-arteritic (NOIANA).

Timeline

Start
2018-06-13
Primary completion
2019-06-13
Completion
2019-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Alprostadil Unknown 20 ug Intravenous

Indications